Economic burden of food allergy

A systematic review

Lucy Ann Bilaver, Avneet S. Chadha, Priyam Doshi, Linda O'Dwyer, Ruchi S Gupta

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Objective: To assess the economic burden of food allergy (FA) worldwide. Data Sources: PubMed MEDLINE, Embase, and Cochrane Central Register of Controlled Trials on the Wiley platform were searched to identify literature that assessed direct, out-of-pocket, and opportunity costs of FA. All databases were searched back to their inception, and no language or date limits were applied. Study Selections: We included primary studies that examined direct medical, out-of-pocket, or opportunity costs and/or lost labor productivity in food allergic adults and/or children and their families. Results: Eleven papers met our inclusion criteria, of which ed7 addressed direct medical, 7 addressed out-of-pocket, and 5 addressed opportunity costs. Estimates were based on data that reflected costs for a patient with FA (individual level) or costs for a household with a food allergic patient (household level). The mean individual-level direct medical costs ($2081) were much higher than the mean household-level costs ($806). The mean individual-level out-of-pocket ($1874) and opportunity ($1038) and opportunity cost were lower than the mean household-level out-of-pocket ($3339) and opportunity ($4881) costs. Household-level estimates of lost opportunity costs imposed the largest economic burden attributable to FA. Conclusion: Most of the economic burden studies reviewed measured components of economic burden that are unique to individuals with FA but did so in noncomparable ways. Addressing cost burdens and measuring them using standardized instruments and methods will be critical to better understand the economic burden of FA globally.

Original languageEnglish (US)
Pages (from-to)373-380.e1
JournalAnnals of Allergy, Asthma and Immunology
Volume122
Issue number4
DOIs
StatePublished - Apr 1 2019

Fingerprint

Food Hypersensitivity
Economics
Costs and Cost Analysis
Food
Information Storage and Retrieval
Health Expenditures
PubMed
MEDLINE
Language
Databases

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Pulmonary and Respiratory Medicine

Cite this

@article{8e3437a4b20e4f76b4099a4f4ee73fec,
title = "Economic burden of food allergy: A systematic review",
abstract = "Objective: To assess the economic burden of food allergy (FA) worldwide. Data Sources: PubMed MEDLINE, Embase, and Cochrane Central Register of Controlled Trials on the Wiley platform were searched to identify literature that assessed direct, out-of-pocket, and opportunity costs of FA. All databases were searched back to their inception, and no language or date limits were applied. Study Selections: We included primary studies that examined direct medical, out-of-pocket, or opportunity costs and/or lost labor productivity in food allergic adults and/or children and their families. Results: Eleven papers met our inclusion criteria, of which ed7 addressed direct medical, 7 addressed out-of-pocket, and 5 addressed opportunity costs. Estimates were based on data that reflected costs for a patient with FA (individual level) or costs for a household with a food allergic patient (household level). The mean individual-level direct medical costs ($2081) were much higher than the mean household-level costs ($806). The mean individual-level out-of-pocket ($1874) and opportunity ($1038) and opportunity cost were lower than the mean household-level out-of-pocket ($3339) and opportunity ($4881) costs. Household-level estimates of lost opportunity costs imposed the largest economic burden attributable to FA. Conclusion: Most of the economic burden studies reviewed measured components of economic burden that are unique to individuals with FA but did so in noncomparable ways. Addressing cost burdens and measuring them using standardized instruments and methods will be critical to better understand the economic burden of FA globally.",
author = "Bilaver, {Lucy Ann} and Chadha, {Avneet S.} and Priyam Doshi and Linda O'Dwyer and Gupta, {Ruchi S}",
year = "2019",
month = "4",
day = "1",
doi = "10.1016/j.anai.2019.01.014",
language = "English (US)",
volume = "122",
pages = "373--380.e1",
journal = "Annals of Allergy, Asthma and Immunology",
issn = "1081-1206",
publisher = "American College of Allergy, Asthma and Immunology",
number = "4",

}

Economic burden of food allergy : A systematic review. / Bilaver, Lucy Ann; Chadha, Avneet S.; Doshi, Priyam; O'Dwyer, Linda; Gupta, Ruchi S.

In: Annals of Allergy, Asthma and Immunology, Vol. 122, No. 4, 01.04.2019, p. 373-380.e1.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Economic burden of food allergy

T2 - A systematic review

AU - Bilaver, Lucy Ann

AU - Chadha, Avneet S.

AU - Doshi, Priyam

AU - O'Dwyer, Linda

AU - Gupta, Ruchi S

PY - 2019/4/1

Y1 - 2019/4/1

N2 - Objective: To assess the economic burden of food allergy (FA) worldwide. Data Sources: PubMed MEDLINE, Embase, and Cochrane Central Register of Controlled Trials on the Wiley platform were searched to identify literature that assessed direct, out-of-pocket, and opportunity costs of FA. All databases were searched back to their inception, and no language or date limits were applied. Study Selections: We included primary studies that examined direct medical, out-of-pocket, or opportunity costs and/or lost labor productivity in food allergic adults and/or children and their families. Results: Eleven papers met our inclusion criteria, of which ed7 addressed direct medical, 7 addressed out-of-pocket, and 5 addressed opportunity costs. Estimates were based on data that reflected costs for a patient with FA (individual level) or costs for a household with a food allergic patient (household level). The mean individual-level direct medical costs ($2081) were much higher than the mean household-level costs ($806). The mean individual-level out-of-pocket ($1874) and opportunity ($1038) and opportunity cost were lower than the mean household-level out-of-pocket ($3339) and opportunity ($4881) costs. Household-level estimates of lost opportunity costs imposed the largest economic burden attributable to FA. Conclusion: Most of the economic burden studies reviewed measured components of economic burden that are unique to individuals with FA but did so in noncomparable ways. Addressing cost burdens and measuring them using standardized instruments and methods will be critical to better understand the economic burden of FA globally.

AB - Objective: To assess the economic burden of food allergy (FA) worldwide. Data Sources: PubMed MEDLINE, Embase, and Cochrane Central Register of Controlled Trials on the Wiley platform were searched to identify literature that assessed direct, out-of-pocket, and opportunity costs of FA. All databases were searched back to their inception, and no language or date limits were applied. Study Selections: We included primary studies that examined direct medical, out-of-pocket, or opportunity costs and/or lost labor productivity in food allergic adults and/or children and their families. Results: Eleven papers met our inclusion criteria, of which ed7 addressed direct medical, 7 addressed out-of-pocket, and 5 addressed opportunity costs. Estimates were based on data that reflected costs for a patient with FA (individual level) or costs for a household with a food allergic patient (household level). The mean individual-level direct medical costs ($2081) were much higher than the mean household-level costs ($806). The mean individual-level out-of-pocket ($1874) and opportunity ($1038) and opportunity cost were lower than the mean household-level out-of-pocket ($3339) and opportunity ($4881) costs. Household-level estimates of lost opportunity costs imposed the largest economic burden attributable to FA. Conclusion: Most of the economic burden studies reviewed measured components of economic burden that are unique to individuals with FA but did so in noncomparable ways. Addressing cost burdens and measuring them using standardized instruments and methods will be critical to better understand the economic burden of FA globally.

UR - http://www.scopus.com/inward/record.url?scp=85063396121&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063396121&partnerID=8YFLogxK

U2 - 10.1016/j.anai.2019.01.014

DO - 10.1016/j.anai.2019.01.014

M3 - Review article

VL - 122

SP - 373-380.e1

JO - Annals of Allergy, Asthma and Immunology

JF - Annals of Allergy, Asthma and Immunology

SN - 1081-1206

IS - 4

ER -